NCT05736081

Short-term Effect of Intravitreal Dexamethasone Implant in Refractory Diabetic Macular Edema

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 15 (actual)
• Sponsor: Asociación para Evitar la Ceguera en México · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial es to learn about the short term effects of intravitreal dexamethasone implant (IDI) in patients with refractory diabetic macular edema. The main question it aims to answer is: How fast does the diminishing in central retinal thickness has statistical significance after IDI in patients with refractory diabetic macular edema? Patients will be evaluated by OCT before and after the implant.

Detailed description

Patients were evaluated at baseline, 2 hours, 3 hours, 24 hours, 1 week and 1 month post IDI

Conditions

• Diabetic Macular Edema

Interventions

Type	Name	Description
DRUG	Intravitreal dexamethasone implant	Intravitreal implant of dexamethasone 0.7 mg with previous topic anesthesia and iodine drops

Timeline

• Start date: 2018-02-15
• Primary completion: 2019-06-30
• Completion: 2019-06-30
• First posted: 2023-02-21
• Last updated: 2024-08-02

Locations

1 site across 1 country: Mexico

Regulatory

• FDA-regulated drug study